Found 86 results
Filters: Author is Melnick, Ari M  [Clear All Filters]
Journal Article
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation., Rivas, Martín A., Meydan Cem, Chin Christopher R., Challman Matt F., Kim Daleum, Bhinder Bhavneet, Kloetgen Andreas, Viny Aaron D., Teater Matt R., McNally Dylan R., et al. , Nat Immunol, 2021 Feb, Volume 22, Issue 2, p.240-253, (2021)
Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML., Li, Sheng, Chen Xiaowen, Wang Jiahui, Meydan Cem, Glass Jacob L., Shih Alan H., Delwel Ruud, Levine Ross L., Mason Christopher E., and Melnick Ari M. , Cancer Discov, 2020 Dec, Volume 10, Issue 12, p.1934-1949, (2020)
SYK inhibition and response prediction in diffuse large B-cell lymphoma., Cheng, Shuhua, Coffey Greg, X Zhang Hannah, Shaknovich Rita, Song Zibo, Lu Pin, Pandey Anjali, Melnick Ari M., Sinha Uma, and Y Wang Lynn , Blood, 2011 Dec 08, Volume 118, Issue 24, p.6342-52, (2011)
Targeted detection and quantitation of histone modifications from 1,000 cells., Abshiru, Nebiyu A., Sikora Jacek W., Camarillo Jeannie M., Morris Juliette A., Compton Philip D., Lee Tak, Neelamraju Yaseswini, Haddox Samuel, Sheridan Caroline, Carroll Martin, et al. , PLoS One, 2020, Volume 15, Issue 10, p.e0240829, (2020)
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate., Venturutti, Leandro, Teater Matt, Zhai Andrew, Chadburn Amy, Babiker Leena, Kim Daleum, Béguelin Wendy, Lee Tak C., Kim Youngjun, Chin Christopher R., et al. , Cell, 2020 Jul 23, Volume 182, Issue 2, p.297-316.e27, (2020)
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis., Dominguez, Pilar M., Ghamlouch Hussein, Rosikiewicz Wojciech, Kumar Parveen, Béguelin Wendy, Fontan Lorena, Rivas Martín A., Pawlikowska Patrycja, Armand Marine, Mouly Enguerran, et al. , Cancer Discov, 2018 Dec, Volume 8, Issue 12, p.1632-1653, (2018)
The theoretical basis of transcriptional therapy of cancer: can it be put into practice?, Melnick, Ari M., Adelson Kerin, and Licht Jonathan D. , J Clin Oncol, 2005 Jun 10, Volume 23, Issue 17, p.3957-70, (2005)
The therapeutic landscape for cells engineered with chimeric antigen receptors., MacKay, Matthew, Afshinnekoo Ebrahim, Rub Jonathan, Hassan Ciaran, Khunte Mihir, Baskaran Nithyashri, Owens Bryan, Liu Lauren, Roboz Gail J., Guzman Monica L., et al. , Nat Biotechnol, 2020 Feb, Volume 38, Issue 2, p.233-244, (2020)
Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage., Chu, Chi-Shuen, Hellmuth Johannes C., Singh Rajat, Ying Hsia-Yuan, Skrabanek Lucy, Teater Matthew R., Doane Ashley S., Elemento Olivier, Melnick Ari M., and Roeder Robert G. , Mol Cell, 2020 Dec 03, Volume 80, Issue 5, p.845-861.e10, (2020)
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma., Jiang, Yanwen, Nie Kui, Redmond David, Melnick Ari M., Tam Wayne, and Elemento Olivier , J Vis Exp, 2015 Dec 28, Issue 106, p.e53215, (2015)
VII. Are lymphomas driven by epigenetic lesions?, Boss, Isaac W., and Melnick Ari M. , Hematol Oncol, 2015 Jun, Volume 33 Suppl 1, p.42-5, (2015)